As per our research analysis report, the global bioinformatics market is forecasted to be worth USD 77.21 billion by 2032 and USD 18.83 billion by 2024, growing at a CAGR of 19.29% during the forecast period.
Bioinformatics combines computer sciences, molecular biology, biotechnology, and statistics. It is a field of collecting, classifying, storing, and analyzing biological and biochemical information by using computer-based software tools. Genomics and proteomics are activities in that bioinformatics are used on a large scale. The field recently includes artificial intelligence and computer sciences for the development in the microbiology and genetic codes section. Additionally, several companies have expanded their innovation in gene expression, gene sequencing, and new drug discovery studies.
The global bioinformatics market is expected to grow significantly by rising government initiatives and funding genomics-based R & D, increasing technology use in drug discovery and biomarker development. In addition, the gradual reduction of DNA sequencing costs is an essential driver of the industry's expected progress and is the primary driver in the global bioinformatics market.
The rise in demand for integrated data and the cost of sequencing decreases create growth opportunities for the market. Besides, the need for nucleic acid and protein sequencing will continue to increase, and increasing proteomics & genomics applications are positively impacting the market's growth. As a result, the global bioinformatics market is expected to grow significantly shortly. Government and private sector investments in the development of innovative products are expected to drive market growth during the forecast period.
The data storage and analysis application that can store large amounts of genomic and proteomic information and facilitate research activities from aging & carcinogenesis to the prevention and treatment of genetic diseases are anticipated to present growth opportunities for the market. Therefore, significant contributions to the development of the industry during the forecast period are also expected in the global bioinformatics market.
The lack of skilled staff, standard data formats, easy-to-use tools available at bargain prices, and the inability to use the platform to integrate large datasets generated by bioinformatics is expected to hinder the bioinformatics market growth.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2024 to 2032 |
Segments Covered |
By Sector, Products & Services, Application, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis; Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
Market Leaders Profiled |
Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc. |
Based on the sector, the medical biotechnology segment is expected to account for the leading share in the global market during the forecast period due to the growing need to develop new drugs at low prices and the use of bioinformatics in pharmaceutical companies to develop drugs. In addition, bioinformatics has the two most traditional applications in the target drug discovery and validation process. Furthermore, the academic sector is also anticipated to grow at a healthy rate in the market during the forecast period due to the development institute's research and projects.
Based on products & services, the knowledge management tools segment is estimated to register the largest share in the global, on the other hand, market. Bioinformatics platforms are the fastest-growing sub-segment based on products & services.
The data analytics is estimated to showcase a robust CAGR from 2024 to 2029 due to the demand for high-performing sequencing data solutions. Furthermore, genetic sequencing is expected to have the fastest growth in the coming years due to rising awareness about genome and exome technologies because of low cost.
Based on the applications segment, Genomics accounts for the largest market share during the forecast period. The genomics application segment is grabbing growth in this market due to increasing the Application in gene sequencing. The proteomics segment is expected to grow in the coming years due to new technologies and several research projects in the bioinformatics market.
Regionally, the North American regional market is predicted to lead the global bioinformatics market, followed by Europe. However, Asia-Pacific is the fastest-growing market in the world. Factors like rising funding for research, growing demand for bioinformatics in proteomics and genomics research, and technological advancements are expected to drive the rise of this market.
The Bioinformatics market in the Asia Pacific will grow fastest, with double-digit expected growth from 2024 to 2032, thanks to the improved healthcare infrastructure and development plans adopted by regional pharmaceutical companies. It is expected to be accomplished. Many infectious disease patients are in the Asia-Pacific region, accelerating the market's demand. APAC accounts for 60% of the world's total population, so a low prevalence means many infected people. Emerging economies, such as India and Australia, also contribute to revenue sharing and progress elsewhere in the Asia-Pacific region. As service outsourcing gains momentum, an increasing number of Asian countries are participating in establishing infrastructure and are expected to influence sector revenue generation through government investment and academic innovation.
The Chinese bioinformatics market is expected to account for the largest share in this regional market during the forecast period due to modern healthcare infrastructure, growing perforation of cutting-edge research, and clinical laboratory techniques driving the bioinformatics market of this APAC region.
The Japanese market is another lucrative region in the Asia Pacific, filled with technological advancements and the growing decoding of genetic sequences. However, a shortage of skilled bioinformatics professionals, high cost, and interaction hamper the growth.
The European market has experienced stable growth in the recent past and is predicted to be the same throughout the forecast period. As a result, this regional market is forecasted to showcase a CAGR of 26.8% from 2024 to 2032. Germany is the fastest-growing market among different nations of Europe and is predicted to hike at a CAGR of 33.12% during the forecast period.
The Latin American region is projected to grow at a healthy CAGR of 16.2% between 2024 to 2032. This regional market was dominated by Brazil in 2023, with over 35%, followed by Mexico.
Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., and major companies operating in the global bioinformatics market Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc. and Waters Corporation.
Several biotech companies and research institutes have taken the initiative to study gene sequencing to grow the bioinformatics market. Using rapid-friendly software such as RasMol and BALL that is used to detect toxicity before the drug discovery processing in the market is a factor that increases the growth of the global market.
By Sector
By Products and Services
By Application
By Region
Frequently Asked Questions
As per our research report, the global bioinformatics market size is estimated to grow to USD 77.21 billion by 2032.
Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag are some of the key market players in bioinformatics market.
The global bioinformatics market is estimated to grow at a CAGR of 19.29% from 2024 to 2032.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region